Arrowhead Pharmaceuticals Profit Margin

The latest profit margin for ARWR is -47.79% as of June 2026. That compares with -26.35% in the prior-year period — down 81.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Arrowhead Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARWR's profit margin moved from -26.35% to -47.79% — a 81.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Arrowhead Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, ARWR currently prints -47.79% for profit margin, while the sector average sits near 13.89%. That is roughly 444.1% below the sector mean. Large gaps often invite a closer look at Arrowhead Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Arrowhead Pharmaceuticals converts resources into returns. At -47.79%, ARWR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -26.35% in the prior-year period — down 81.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ARWR's profit margin (-47.79%), review year-over-year change from -26.35%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.